Parmeshwari K Halen, Prashant R Murumkar, Rajani Giridhar, Mange Ram Yadav
Index: Mini Rev. Med. Chem. 9(1) , 124-39, (2009)
Full Text: HTML
Non-steroidal anti-inflammatory drugs (NSAIDs), commonly used for the treatment of chronic inflammatory diseases suffer from several undesired side effects, the most important being gastrointestinal (GI) irritation and ulceration. The prodrug designing is one of the several strategies used to overcome this drawback. The rationale behind the prodrug concept is to achieve temporary blockade of the free carboxylic group present in the NSAIDs till their systemic absorption. In this paper, a review on the concept of prodrugs designing of NSAIDs to improve their efficacy and reduce the toxicity is being presented.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
glycolamide
CAS:598-42-5 |
C2H5NO2 |
|
Isolation of amidase-negative mutants of Pseudomonas aerugin...
1987-06-01 [J. Gen. Microbiol. 133(6) , 1527-33, (1987)] |
|
Extraction capacity of diglycolamide derivatives for Ca(II),...
2005-10-01 [Anal. Sci. 21(10) , 1171-5, (2005)] |
|
Synthesis and evaluation ofin vitroanti-tuberculosis activit...
2009-01-01 [Eur. J. Med. Chem. 44(1) , 289-95, (2009)] |
|
Activity profile of glycolamide ester prodrugs of ibuprofen.
2001-01-01 [Drug Dev. Ind. Pharm. 27(1) , 63-70, (2001)] |
|
A QSAR approach for the prediction of stability of benzoglyc...
2006-08-01 [Chem. Pharm. Bull. 54(8) , 1067-71, (2006)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2026 ChemSrc All Rights Reserved
